Redeye makes minor estimate revisions following Arise’s Q2 report, which was very much in line with Redeye’s estimates. We think the quarter was stable, and although the spot prices were low, Arise realised a high revenue per MWh due to favourable price hedges. Ongoing constructions are proceeding according to plan, and the project portfolio is growing and maturing – which we think supports Arise’s journey to reaching its financial targets.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/